EMV 0.47% $2.16 emvision medical devices ltd

Ann: Appendix 4E & Annual Report 30 June 2021, page-8

  1. 13,496 Posts.
    lightbulb Created with Sketch. 2686
    This is an incredibly positive update. Ron is not one to deliver unsupported hype. He is far too prudent and measured for that. He knows where EMV stands and what is still required - because he has been through it before and he has assembled a high quality team to do it all again.

    The update tells me that Ron knows he has the goods and that it is just a matter of continuing through the processes. The ASA partnership has been incredibly fortuitous and has increased the size of the cake and added icing to it.

    The positive language in the update tells the story. I have paraphrased it here to underline the positive strength of the words used:

    Well on the way - global leader - strong strides - achieved important milestones - important breakthroughs - rapidly advancing - incredibly exciting milestone - truly change the landscape of stroke care - engagement with regulatory bodies positive to date - expertise in developing products to international medical device standards - deploy our neuroimaging products globally - incredibly proud of role in the Australian Stroke Alliance’s program - drive a technology revolution - create a template with global reproducibility - potential for truly global health impact is enormous - another exciting year for EMVision
    Last edited by vintage: 01/09/21
 
watchlist Created with Sketch. Add EMV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.